Searchable abstracts of presentations at key conferences in endocrinology

ea0035p165 | Calcium and Vitamin D metabolism | ECE2014

Evaluation of vitamin D concentration in a population of young, healthy women: effects of vitamin D supplementation

Sewerynek Ewa , Cieslak Karol , Janik Malgorzata , Stuss Michal

Vitamin D and calcium are necessary for proper modelling and remodelling of osseous tissue and optimal bone mass depends on their appropriate supplementation.Aim of study, materials and methods: The goal of the study was an evaluation of serum vitamin D concentrations (vit. D) in 106 healthy women, aged 20–30 years plus a monthly evaluation – for 3 months – of the effects of calcium (500 mg) and vit. D (1500 IU) administration in women wit...

ea0014p7 | (1) | ECE2007

Effects of melatonin on glutathione peroxidase activity after adriamycin in normal and pinealectomized rats

Dabrowska Katarzyna , Stuss Michal , Gromadzinska Jolanta , Wasowicz Wojciech , Sewerynek Ewa

Adriamycin (ADR) is a potent chemotherapeutic agent, effective in treatment of leukemias, lymphomas and of many solid tumours. However, its clinical usage is often limited by cardiotoxicity, induced by oxygen radical damage of membrane lipids.Melatonin (MEL), is a well-known antioxidant. It has been shown that melatonin can scavenge free radicals, both directly or indirectly, stimulating the activity of antioxidative enzyme, e.g., glutathione peroxidase ...

ea0035p97 | Bone and Osteoporosis | ECE2014

Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells after treatment with hormonal replacement therapy and tibolone in patients after menopause with osteopenia or postmenopausal osteoporosis

Stuss Michal , Ceglowska Agnieszka , Rieske Piotr , Stepien-Klos Wioletta , Liberski Pawel , Sewerynek Ewa

The aim of the reported study was to assess gene expression levels of the OPG/RANK/RANKL system in peripheral blood mononuclear cells (PBMC) after tibolone and hormonal replacement therapy (HRT) administered to patients with oestrogen deficiency symptoms and osteopenia or postmenopausal osteoporosis.Material and methods: 74 women after menopause, aged 45–71 years, were enrolled into the study and randomly assigned to different medical therapies: HRT...

ea0035p98 | Bone and Osteoporosis | ECE2014

Assessment of OPG and RANKL serum levels after treatment with hormonal replacement therapy and tibolone in patients after menopause with osteopenia or postmenopausal osteoporosis

Stuss Michal , Ceglowska Agnieszka , Rieske Piotr , Stepien-Klos Wioletta , Liberski Pawel , Sewerynek Ewa

The aim of this study was to evaluate quantitative changes in OPG and RANKL proteins after tibolone and hormonal replacement therapy (HRT) administered to patients with oestrogen deficiency symptoms and osteopenia or postmenopausal osteoporosis.Material and methods: A total of 74 women after menopause, aged 45–71 years, patients of the Outpatient Clinic of Osteoporosis of the Military Teaching Hospital in Lodz, were enrolled into the study. The pati...